Archive for July, 2010

Psychiatric Meds 101: A Surprising Discovery – Your Own Personal Hell

Tuesday, July 20th, 2010

Mouse over image and click to see next slide. To copy/post slideshow use the embed code at bottom of page.

By Shane “The People’s Chemist” Ellison
Author, Over-The-Counter Natural Cures

I may be a perfect candidate for psychiatry.

I ask questions with period marks to shorten conversations. I avoid eye contact with strangers in fear (maybe it’s anxiety) that I might learn too much about them. I secretly think that Metallica would be making better music if they went back to bludgeoning themselves with party drugs and alcohol, instead of “therapy.” I’m trying to master the Law of Un-attraction to shield myself from a “real job,” small homes and junky cars.  And, I’m constantly giving my children advice, only to give it to myself.

Psychiatry, can your drugs help me?

Perhaps these questions are what motivated me to pursue a career as a drug design chemist, winning multiple awards for my work. Nothing gets me more excited than drugs and how they affect the body (except my wife’s abs). I’ve studied their molecular anatomy, risked life and limb to mix and match explosive chemicals in a round bottom flask, and even sold my soul to Big Pharma in exchange for a lab bench and chemical hood.

During this time, I’ve made some surprising discoveries about psychiatric meds, which include antidepressants, antipsychotics, stimulants, and anti-anxiety drugs. Understanding what I’ve learned will protect you from the flood of side effects that are now being discovered at breakneck speeds, courtesy of the myriad of patients being prescribed psychiatric drugs in the name of mental health.

Your Own Personal Hell

Antidepressants strive to increase the levels of a “coping” molecule known as serotonin in the brain. It supposedly helps us find happiness when it’s covered in an avalanche of nastiness. But, it’s never been proven. Still, the drugs attempt to boost serotonin by “selectively” stopping the “reuptake” among brain cells. This is where the whole SSRI acronym came from—“selective serotonin reuptake inhibitor.” It’s a slick name, but a stupid idea. Nothing is selective in the body.

While trying to block the reuptake of serotonin, antidepressants can also prevent its release and that of another brain compound known as dopamine. The areas of the brain responsible for release and reuptake of these neurotransmitters are so damn similar (after all, they work on the same molecule) that an antidepressant drug isn’t smart enough to understand which one it is supposed to work on. So it does what any dumb drug would do, it blocks both. That’s why users usually carry a glassy stare in their eye. Fully under the psychiatric spell, they’ve tuned out.

Deep sadness, fear, anger and aggression can set in over time. By removing serotonin and dopamine from the brain, long-term antidepressant users can’t find or feel happiness. Instead, they may become buried in the avalanche of nastiness. And if you can’t find or feel happiness in life, what’s the point? What’s going to stop you from snapping your own neck or spraying bullets on your classmates? Not much when you live in your own personal antidepressant hell.

Think this is all opinion?

According to the FDA, antidepressants can cause suicidal thoughts and behavior, worsening depression, anxiety, panic attacks, insomnia, irritability, hostility, impulsivity, aggression, psychotic episodes and violence.  Some even cause homicidal ideation according to the manufacturers. Many long-term antidepressant users will tell you they no longer feel normal emotions—they’re numb, like zombies.

But the side effects of these drugs aren’t limited to hijacking your feelings and emotional state, causing violent and psychotic states. Physical side effects occur too and include abnormal bleeding, birth defects, heart attack, seizures and sudden death. Over one hundred and seventy drug regulatory warnings and studies have been issued on antidepressants, to sound the alarm on these side effects.

For Elephant Use Only

Psychiatrists prescribe antipsychotic meds such as Zyprexa and Seroquel, for anything from schizophrenia, bipolar disorder, delusional disorder, psychotic depression, autism or anything else they can think of, even “pervasive developmental disorder,” which is perfect for boosting sales because it targets children who suffer from irritability, aggression, and agitation. It’s a shame ‘cause these drugs are good for nothing but sedating irate elephants, not curing psychiatric disease.

According to a study published in Psychological Medicine, antipsychotic drugs cause brains to shrink – they lessen brain matter and volume. Originally designed for those deemed “schizophrenic,” the drug companies came up with a brilliant marketing campaign to sell these drugs to a much wider market—unsatisfied antidepressant users. You’ve probably seen the ads—if your “depression medication” isn’t working, then don’t blame the drug; you may just have bipolar disorder!

Once swallowed, antipsychotics sail through the blood stream where they’re carried to the brain. Like a giant oil spill, antipsychotics cover the brain in a medicinal slick, where brain wave transmission is blocked. Users become devoid of normal brain activity. Motivation, drive and feelings of reward are shunted. If psychiatry considers this a “treatment,” they’re the crazy ones.

If you’ve ever seen someone who has suffered from the “spill” courtesy of following doctors orders, you can’t mistake one of the most common side effects, it’s called Akathisia. Involuntary movements, tics, jerks in the face and the entire body can become permanent side effects for antipsychotic users.

Antipsychotics also cause obesity, diabetes, stroke, cardiac events, respiratory problems, delusional thinking and psychosis. Drug regulators from the U.S., Canada, United Kingdom, Ireland, Australia, New Zealand and South Africa warn that they can also lead to death. I wouldn’t be surprised if psychiatrists considered this a cure…

Use This to Jump The Grand Canyon

If you’re going to attempt to jump your scooter over the Grand Canyon, or ride your snowboard off Kilimanjaro, stimulants are great. They flood the brain with dopamine and trigger an inhuman surge of adrenaline, responsible for making you believe life is grand, despite eminent death. Outside of that, you’re either a speed freak, a college student trying to learn an entire semester of Biology 101 in 4 hours, or a fifth grader “following doctor’s orders.”

Top stimulants being prescribed today are nothing more than a mix of amphetamines packaged into trade names like Adderall, Dexedrine and Ritalin.  Street thugs sell it as meth, poor man’s cocaine, crystal, ice, glass and speed. It’s no wonder kids are now abusing Ritalin, Adderall and these drugs more than street drugs, they’re cheaper to get and they’re “legal,” hence the term kiddie cocaine.

Even the U.S. Drug Enforcement Administration (DEA) categorizes Ritalin in the Schedule ll category, meaning a high potential for abuse—just like cocaine and morphine. All of them have the same effects regardless of how they’re named: Central nervous system overload leading to heart attack and/or heart failure. And kids are dropping faster than Meth Heads at Raves…

I’m not exaggerating.

Eleven international drug regulatory agencies and our own FDA has issued warnings that stimulants like Ritalin cause addiction, depression, insomnia, drug dependence, mania, psychosis, heart problems, stroke and sudden death.

 Bash Your Head in with Anti-Anxiety Drugs

If you’re not man enough for a drug that could sedate an elephant like antipsychotics, then psychiatrists will prescribe anti-anxiety meds, particularly benzodiazepines. Choosing between the two is akin to deciding whether or not you should be hit in the head with an aluminum bat or a wooden one; anti-anxiety meds being the latter.

Discovered in the stinky chemistry labs of Hoffman La Roche in 1955, anti-anxiety meds aim to trigger sleep receptors in the brain, just slightly. So, rather than being riddled with anxiety, you are put to sleep, halfway. It’s “treatment,” and psychiatrists have been “practicing it for decades.” But, it has yet to work, because drugging your problems away is more dangerous than anxiety. The use of anti-anxiety meds is coupled with a host of nasty side effects such as seizures, aggression and violence once the drug wears off. Hallucinations, delusional thinking, confusion, abnormal behavior, hostility, agitation, irritability, depression and suicidal thinking are all possible outcomes according to Big Pharma’s heavily guarded research papers.

Getting off the drugs could be harder than abandoning a heroin addiction. Some have described withdrawal from “benzos” being akin to pulling hundreds of fish hooks out of their skin, without anesthesia. If you doubt their addictive nature, go to Google search and type in a few of the leading anti-anxiety drugs like Klonopin or Xanax and here is what you’ll find:

“Klonopin withdrawal” 1,860,000 results

“Xanax withdrawal” 1,980,000 results

Exposing Psychiatry: How to Get The Truth

In total, the side effects of psychiatric meds spread far and wide. And most are hidden from patients and doctors alike. Fortunately, Citizens Commission on Human Rights has solved this problem with a state-of-the-art database that allows people to search through the adverse reaction reports sent to the FDA on psychiatric drugs. It also provides international drug regulatory agency warnings and studies published on the side effects of the drugs.

So, can psychiatry help me? No. And that’s surprising because psychiatric meds are some of the biggest selling drugs, poised to seal the hopes and dreams of millions.  Regardless of what mental state I might be in (or anyone else for that matter), there is not a single drug that cures, treats or solves the perceived problems of mental health.

While people can suffer miserably from emotional or mental duress that can hinder their lifestyle, the pseudo-science of psychiatry has yet to solve any of these problems, and in fact only contributes to poor health as seen by the wide array of side effects. Marketing campaigns and ghostwritten medical journals are designed to obscure these facts. But the psychiatric drug side effect database courtesy of CCHR ensures that all patients have access to the truth, to the documented facts, which could save their life or that of a loved one.

 About the Author

Shane Ellison holds a masters degree in organic chemistry and is the author of Over-The-Counter Natural Cures.  An award winning chemist, he has been quoted by USA Today, Shape, Woman’s World, as well as Women’s Health and appeared on Fox and NBC as a natural medicine advocate.  Sample his book free at www.thepeopleschemist.com

————————————————————————–

To use this slideshow on your own website, you can use one of these two embed codes:

<object data=”http://www.cchrint.org/slideshow/index.html” width=”593″  height=”440″ style=”overflow:hidden; height:440px; width:593;”><embed src=”http://www.cchrint.org/slideshow/index.html” width=”593″ height=”440″ style=”overflow:hidden; height:440px; width:593;”> </embed>Error: Embedded data could not be displayed.</object>

OR

<iframe src=”http://www.cchrint.org/slideshow/index.html” width=”593″  height=”440″ style=”border:none; overflow:hidden;”></iframe>

RETURN TO BLOGS PAGE


Share

The Los Angeles Examiner: Psychiatric Overdiagnosis Means “Normal” Could Become Obsolete

Tuesday, July 20th, 2010

Examiner.com
By jenny Westberg
July 13, 2010

An intolerance of individual differences, according to some, has led to overdiagnosis.

Are you normal? Are you sure?

A growing number of behaviors and moods are being relabeled as mental disorders, according to two recent articles. Sadness, shyness, personality quirks and the ups and downs of everyday life may qualify almost anyone for a psychiatric diagnosis, effectively pathologizing normality.

Allen Francis, MD writes in the Psychiatric Times that almost everyone meets the criteria for one or another of the conditions listed in the Diagnostic and Statistical Manual of Mental Disorders, the book psychiatrists use to determine whether you have a mental illness. The fifth edition of the manual (DSM-5), due in 2013, will relax these criteria even further, giving psychiatric labels to even more people.

According to 2010 figures from the National Institute of Mental Health (NIMH), more than 25 percent of the adult population has a diagnosable mental disorder. That’s approximately 60 million people. A prospective study found that, by age 32, half of U.S. adults could be diagnosed with anxiety; 40 percent with depression; and 30 percent with alcohol abuse or dependence.

With criteria proposed for the DSM-5, psychiatrists could diagnose “Nicotine Use Disorder” or “Caffeine-Induced Sleep Disorder.” If your child has temper tantrums, that’s one of the signs of “Temper Dysregulation Disorder with Dysphoria.” Bad dreams? It could be a case of “Nightmare Disorder.”

Why is this a problem? Mental illness carries a stigma. A diagnostic label can follow you for the rest of your life. It is shared with your insurance company. Your family and friends might make certain assumptions about you. Your doctor may insist you need psychiatric drugs.

More and more behaviors, however, are being stamped as “mental illnesses.”

Francis writes that individual differences that were once accepted as normal have become medicalized. Our society, he says, has become perfectionistic and intolerant of even short-term distress.

Read entire article:  http://www.examiner.com/x-31400-Portland-Mental-Health-Examiner~y2010m7d13-Psychiatric-overdiagnosis-means-normal-could-become-obsolete

« Return to news items


Share

GlaxoSmithKline settles case with woman who linked her use of antidepressant Paxil to the death of her infant son

Monday, July 19th, 2010

The Associated Press
By Wayne Ortman
July 19, 2010

SIOUX FALLS, S.D. — A settlement has been reached in a lawsuit filed against a pharmaceutical company by a Watertown woman who linked her prescribed use of Paxil to the death of her infant son, according to court files.

Jennifer Berg of Watertown sued SmithKline Beecham, doing business as GlaxoSmithKline, in October 2007. The complaint said Nathan Berg died in 2004 because of a heart disorder caused by her use of the antidepressant Paxil while she was pregnant.

The federal court lawsuit sought unspecified damages from the company for failing to warn of a link between the two. Letters from her attorneys to the presiding judge indicate there’s a settlement. No settlement documents have been filed in court.

Lawyers at a California firm handling the case for Berg did not immediately return a phone call Monday for comment.

GlaxoSmithKline said last week that it expects to take a $2.36 billion charge against second-quarter earnings for settlements, agreements to settle and other provisions for long-standing legal cases over Paxil, the diabetes drug Avandia and other issues. The company said settlement details would be confidential.

According to the lawsuit, Nathan Berg was born Aug. 20, 2004 at Watertown and was immediately transferred to a Minneapolis hospital where he died 58 days later of Persistent Pulmonary Hypertension of the Newborn (PPHN), a disorder which prevents proper oxygenation of the blood.

“At the time Paxil was prescribed to Ms. Berg, GSK (GlaxoSmithKline) knew or should have known through pre-market studies and post-market studies and reports that Paxil was associated with an increased risk of PPHN in babies whose mothers ingested Paxil during pregnancy,” according to the lawsuit.

Read entire article:  http://www.google.com/hostednews/ap/article/ALeqM5j7UU4otrHhelqaJFcC3ttvwj4bYgD9H29RK00

« Return to news items


Share

New study linking anti-psychotics to brain damage raises alarm bells with health campaigners & human rights groups

Monday, July 19th, 2010

Black Mental Health UK
By Zephaniah Samuels
July 18, 2010

Findings from a new study that shows that anti-psychotic drugs are likely to cause brain damage has raised alarm bells among  health campaigners and human rights groups.

Effects of antipsychotics on brain volume

Entitled ‘A systematic review of the effects of antipsychotic drugs on brain volume ,’ the results of this study dispel the widely-held view that schizophrenia itself causes brain structural changes.  ‘Some evidence points towards the possibility that antipsychotic drugs reduce the volume of brain matter and increase ventricular or fluid volume. Antipsychotics may contribute to the genesis of some of the abnormalities usually attributed to schizophrenia,’ the report says.

Published in the journal of Psychological Medicine these new findings are based on a review of the effects of antipsychotic drugs on the brain. The findings  published earlier this year, have raised alarm among race equality and human rights groups who are increasingly concerned  about the over-diagnosis of  ‘schizophrenia’ among  people from  African Caribbean people communities.

The annual Count Me In Census report logs the ethnic origin of those admitted into psychiatric care including those detained against their will under the Mental Health Act.

For the past four years census findings have shown that rates of forced detention of black people under the Act continue to rise while falling for the rest of the population.  The results of the latest 2009 Census published earlier this year again confirmed health campaigners worst fears, that absolutely no improvement has been made to reduce the detention rate of black people sectioned under the Mental Health Act despite the former government’s million pound programmed to address the racism and  within mental health service.

African Caribbean’s routinely given diagnosis of schizophrenia

Once in the system evidence shows that black people are routinely given a diagnosis of schizophrenia even though there is no biological evidence to show that this group have higher rates of mental ill health than their white counter parts.

The diagnosis of schizophrenia is routinely accompanied by a regime of antipsychotic medication, with little evidence of those who enter the system ever making a full recovery.

A report by the now defunct Mental Health Act Commission  entitled, Risks, Rights and Recovery published in 2008 show that over stretched staff are regularly  give patients high doses of medication in order to make patients more easy to manage.

This latest paper challenges the view that schizophrenia itself causes brain structural changes, such as less brain grey matter, larger ventricles and more cerebrospinal fluid (CSF) spaces, researchers say.  The team responsible for this work reviewed magnetic resonance imaging studies, which had assessed brain changes in patient on anti-psychotic and those of patients not on the drugs.

Over half of the 26 studies showed that the brains of patients on anti-psychotics had shrunk. This was compared to the 21 studies of patients who had not be given anti-psychotics, where just five showed brain size decreases.  However no differences were reported in three studies of non-drug patients who had been ill for a long time.

Read entire article:  http://www.blackmentalhealth.org.uk/index.php?option=com_content&task=view&id=805&Itemid=117

« Return to news items


Share

Death of 7-year old prompts Florida officials to ask FDA to forbid allowing foster kids as guinea pigs in drug trials

Monday, July 19th, 2010

Pharmalot
By Ed Silverman
July 19, 2010

Last year, a 7-year-old foster boy named Gabriel Myers committed suicide in Florida and, after reams of publicity and hand-wringing over the use of psychotropic medications in such children, a state task force recommended, among other things, that children never be allowed to participate in a clinical trial designed to evaluate new psychotropic meds or whether such drugs approved for adults should be given to children.

The move was prompted, in part, because a Florida psychiatrist, Sohail Punjwani, who treated the boy before he committed suicide, received an FDA warning letter for failing “to protect the rights, safety and welfare” of children enrolled in clinical trials (back story). Before the suicide, the psychiatrist prescribed to kids several drugs, some of which weren’t approved by the FDA for use on children and had been linked to dangerous side effects, including an increased risk of suicide among children (back story).

As part of the follow-up, George Sheldon, who head’s Florida’s Department of Children and Families, wrote FDA commish Margaret Hamburg for info about any foster children who might have participated in clinical trials for psychotropic meds (read the letter) and asked the FDA to forbid foster kids from participating in these trials. Last month, the agency wrote back to say the agency does not agree with a “blanket prohibition” on enrolling foster children. Why? Such a policy fails to account for the greater risk of off-label prescribing and research involving children can yield benefits that cannot be obtained by tracking usage in adults, Jill Warner, acting associate commissioner for the FDA’s Special Medical Programs, wrote back (see here). Drugmakers, by the way, also have something at stake – they receive an extra six months of marketing exclusivity in return for having conducted the pediatric trials.

We asked Florida officials if they are rethinking their position. The answer? No way. The state is resolute.

Read entire article:  http://www.pharmalot.com/2010/07/florida-tells-fda-no-children-in-psychotropic-trials/?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+Pharmalot+%28Pharmalot

« Return to news items


Share

Prescription Drug Epidemic Spreads to Babies

Friday, July 16th, 2010

St. Petersburg Times
By Richard Martin
July 16, 2010

Dr. Mary Newport sees the symptoms more and more in the babies she treats: oddly stiff limbs, severe tremors, vomiting, diarrhea, insomnia, crying that never stops.

The common denominator: Their mothers were taking prescription drugs, mostly painkillers like OxyContin and Vicodin, and antianxiety drugs like Xanax during pregnancy.

Some of the moms had no idea these medications would hurt their developing babies — after all, it’s not like it’s heroin or cocaine, many think.

“They are seriously misinformed,” said Newport, medical director of Spring Hill Regional Hospital’s neonatal intensive care unit.

The prescription drug epidemic, well documented among teens and adults, now is claiming victims before they are even born. Tampa Bay area doctors and addiction specialists are reporting a dramatic increase in the number of pregnant addicts and infants needing treatment for withdrawal from prescription drugs.

The trend is reminiscent of the “crack baby” epidemic of the 1980s, when mothers used crack cocaine during their pregnancies.

But area neonatologists say that in some ways, the current trend is worse. Some women don’t understand that prescription drugs can be dangerous during pregnancy. Others decide to stop the drugs as soon as they learn they are pregnant, causing sudden withdrawal that can lead to miscarriage.

And doctors say that treating a baby with drugs like oxycodone, methadone or Xanax in the system takes longer, and involves more medication, than treatment for heroin or cocaine.

“Babies are suffering more,” said Dr. Terri Ashmeade, medical director of Tampa General Hospital’s neonatal intensive care unit. “Withdrawal patterns seem to be worse (with prescription drugs) than what we were seeing with heroin.”

Note from CCHR Int: To see for yourself what psychiatric drug reactions for infants and babies have been reported to the U.S. FDA’s medwatch system (by doctors, pharmacists, consumers etc),  go to our decrypted Medwatch reports: Under the drop down menu for DRUG NAME/DRUG CLASS, scroll all the way down to the bottom until you see CLASS OF DRUGS such as ATYPICAL ANTIPSYCHOTICS or ANTIDEPRESSANTS or STIMULANTS and select one of those.   In the AGE RANGE drop down menu select 0-1 year old then click GENERATE REPORT.   You can do this for each class of psychiatric drug.  And consider this,   by the FDA’s own admission, only 1-10% of side effects are ever reported, so the actual side effects occurring in the general population are much higher.

Click here for Decrypted Medwatch Reports http://www.cchrint.org/psychdrugdangers/medwatch_psych_drug_adverse_reactions.php

Click her to read the rest of the article:  http://www.tampabay.com/news/health/article1109348.ece

« Return to news items


Share

Glaxo To Book $2.4 billion To Settle Legal Cases, Including Avandia, Paxil

Thursday, July 15th, 2010

USANewsweek
July 15, 2010

British Pharma giant GlaxoSmithKline is expected to record a legal charge of $2.4 billion for the second quarter of this fiscal year in order to settle legal cases relating to its antidepressant Paxil and controversial diabetes pill Avandia. The British company announced two days ago that the money would be used not only to cover the settlements for Avandia but also other long-standing legal cases. It is learnt that the company would use the money to settle an investigation into its former factory at Cidra in Puerto Rico as well.

The news of the hefty charge, which is around 2.5 percent of the market value of the British drug maker took the edge off an expected rally in the shares after a U.S. panel allowed the company to Avandia in stores but the panel asked Glaxo to include new warnings on heart risks. “Some people might baulk at the size of the charge but probably most will say this is putting it all behind the company, so we can now look to the continuing business and view the stock on a more rational basis,” said Deutsche Bank analyst Mark Clark.

Menwhile, Glaxo did not divulge how much it was setting aside to settle legal issues related to Avandia. The company defended its decision saying that settlement terms were confidential. Earlier, it was reported that Glaxo might have to spend a whopping $6 billion to resolve legal cases related to Avandia but the panel vote allowing the company to keep the drug in market means that the company would be able to settle the claims by paying around $1 billion.

Read entire article:  http://www.usanewsweek.com/news/Glaxo-To-Book-2-4-billion-To-Settle-Legal-Cases–Including-Avandia–Paxil-1279232979/

« Return to news items


Share

SSRIs Render Unfriendly Skies—FOIA documents reveal what FAA failed to consider in allowing pilots on antidepressants to fly

Wednesday, July 14th, 2010

Scoop Independent News
By Evelyn Pringle
July 14, 2010

The SSRI antidepressant makers are desperate to find new customers, so they recently have been focusing on capturing groups for which the drugs were usually considered off limits. The latest marketing coup managed to open up sales to roughly 614,000 American pilots.

Under a new policy announced on April 5, 2010, pilots diagnosed with depression can seek permission from the Federal Aviation Administration to take one of four SSRIs, including Eli Lilly’s Prozac, Pfizer’s Zoloft, and Forest Laboratories’ Celexa and Lexapro.

“The FAA should reverse its ruling before it’s too late and hundreds of lives are lost when a pilot becomes impulsive, suicidal or violent–or just loses his sharpness–under the influence of antidepressant medication,” said SSRI expert, Dr Peter Breggin, in an April 19, 2010 Huffington Post commentary.

The Citizens Commission on Human Rights is also calling on the FAA to rethink allowing pilots to take SSRI in light of a new report issued last month by the National Transportation Safety Board, on a February 1, 2008 plane crash in North Carolina, by a crazy acting pilot on Zoloft, that killed all six persons on board

The report said the pilot failed to maintain control of the plane during instrument flying conditions and “deliberately descended below the minimum descent altitude.” The plane stalled and crashed while circling after an aborted landing.

“Review of the cockpit voice recorder (CVR) audio revealed that the pilot had displayed some non-professional behavior before initiating the approach,” the NTSB reported.

The CVR recorded the pilot singing: “Save my life I’m going down for the last time,” before beginning a commentary in which he told passengers: “If anybody back there believes in the good Lord, I believe now would be a good time to hit your knees.”

A review of medical records documented that “from December 4, 2006 through December 31, 2007, the pilot had filled 6 prescriptions for 30 tablets of 50 mg sertraline (Zoloft),” the report said.

The records indicated that he had been treated previously with two other antidepressant medications for “anxiety and depression” and a history of “impatience” and “compulsiveness,” the NTSB noted.

An investigation of another plane crash, resulting in two fatalities in Kingsport, Tennessee, in August 2003, found Zoloft in the blood and liver of a private flight instructor, according to an accident report by the NTSB.

In the policy statement published in the Federal Register, the FAA seems to justify the use of these drugs via the fully debunked “chemical imbalance in the brain” theory when writing: “All these medications are SSRIs, antidepressants that help restore the balance of serotonin, a naturally occurring chemical substance found in the brain.”

“Increasingly accepted and prevalently used, these four antidepressants may be used safely in appropriate cases with proper oversight and have fewer side effects than previous generations of antidepressants,” the FAA wrote, with no citation to any scientific paper to back up this assertion.

In fact, the current labels on SSRIs warn that “anxiety, agitation, panic attacks, insomnia, irritability, hostility, aggressiveness, impulsivity, akathisia (psychomotor restlessness), hypomania, and mania, have been reported in adult and pediatric patients treated for major depressive disorder as well as for other indications, both psychiatric and nonpsychiatric.”

“Even when not severe, these reactions impair judgment and increase the likelihood of accidents and violence,” according to Dr Breggin.

CCHR has set up a great website with a one-of-a-kind search engine that allows the public and officials to access the database on side effects reported to the FDA on SSRIs, and every other psychiatric drug. The site also has a search engine to access all the International warnings and studies on psychiatric drugs which have been summarized so they are easy to understand, even to a lay person.

Input Only From the Choir

On April 6, 2010, Bob Fiddaman, author of the long-running popular website and blog, “Seroxat Sufferers,” sent a request to the FAA, under the Freedom of Information Act, seeking information on the change in policy.

In the Federal Register, the FAA claims it came to its decision after “careful consideration.” However, in the 58 pages of documents sent to Fiddaman on June 9, 2010 (and kindly shared with this author), there is no mention of consultations with any of the prominent SSRI experts who may have offered a contrary view. Like Peter Breggin for instance.

The FAA’s response to Fiddaman shows the agency has been discussing the policy change since at least 2008. In response to a request for “minutes of meetings where the change in the policy was on the agenda,” as well as a list of “members present and a declaration of interests of each of the members,” the FAA sent a copy of a July 18, 2008, Memorandum, with a summary from one consultants meeting. Three outside experts attended but there were no declarations of interests, or lack thereof, by anyone at the meeting.

The summary noted that the consultants “unanimously agreed that the concept of allowing certain airmen taking antidepressant medication was reasonable and safe.” But the “unanimous consensus” was that only Prozac and Zoloft “were appropriate medications due to the longevity of their use and overall safety.”

“They also felt that only these two should be considered initially, and no other medications considered at this time,” the summary reported.

In responding to the question of whether the new policy would apply to Air Traffic Controllers, the FAA said the “new policy does not presently apply to Air Traffic Control Specialist (ATCS) because the administrative details of the monitoring and follow-up of these employees are yet to be determined. The plan is that ATCSs will eventually be included in a program of this type.”

In response to a request for any information “given to FAA from outside parties that relate to the FAA’S recent change in policy regarding pilots on antidepressant medication,” the FAA sent copies of documents received from the Aerospace Medical Association, the Airline Pilots Association Aeromedical Office, the International Airline Pilots Association, and the United States Army.

“In developing the new policy, the FAA also utilized a variety of medical research literature available in the public domain,” the response said. “We used internet sites such as, but not limited to: The National Library of Medicine PubMed site and the FDA Medwatch.”

The documents Fiddaman received show consideration of a 2003 study of aviation accidents that found SSRIs in 61 pilot fatalities between 1990-2001, in which the psychological condition and/or the drug use was determined to be the cause, or a factor in 16 of the accidents, or 31%.

However, there was no mention of a later November 2006 study titled, “Pilot Medical History and Medications Found in Post Mortem Specimens for Aviation Accidents,” led by Dennis Canfield, from the FAA’s Civil Aerospace Medical Institute, in the “Aviation, Space, and Environmental Medicine” journal.

For this study, toxicological evaluations were performed on 4,143 pilots involved in fatal aviation accidents during the period between January 1, 1993, through December 31, 2003, to identify all pilots found positive for medications used to treat cardiovascular, psychological, or neurological conditions.

The evaluations found one-hundred dead pilots with SSRIs in their systems including forty with Prozac, twenty-six with Zoloft, twenty-one with Paxil, and thirteen with Celexa.

Less than a month after the new policy was announced, in “Aviation International News,” on May 1, 2010, Matt Thurber reported that in a review of 127 accidents in the NTSB database since 1991, containing the word “antidepressant,” only three were nonfatal.

“In 124 of those accidents, 211 people were killed,” Thurber said. “In accident after accident, antidepressants … were found in the tissues of dead pilots, and the pilots had falsified their medical certificate applications to show that they had never been treated for psychiatric problems.”

Read the rest of this article here:  http://www.scoop.co.nz/stories/HL1007/S00116.htm

Read FOIA documents here: http://fiddaman.blogspot.com/p/faa-respond-to-freedom-of-information.html

« Return to news items


Share

The Huffington Post—Life is Not a Mental Disorder

Tuesday, July 13th, 2010

The Huffington Post
By Ronald Ricker
July 13, 2010

The Bible (or really any religious text) can be made to say and mean anything the author wishes.

The “Bible” of psychiatry, that fabled and hoary text, the DSM-IV-TR (Diagnostic Statistical Manual of Mental Disorders written by the American Psychiatric Association), is no different. Conceived as an instrument to identify and help heal disorders of the mind, it has morphed as to both form and function. Too often, psychiatrists wield the DSM-IV-TR like a blunt instrument, desperate in their drive to assign names to supposed “mental conditions” and thus to be able to assign numbers to these “conditions.” Discover a new widely inclusive “condition,” give it a name and number and you have a winner: One more brick in the wall of sicknesses.

DSM-IV-TR is very large book. We have lots of diagnoses, the number rapidly growing. We need lots of page room. Aside from blank pages, Chapter Heading Pages, and long lists of Contributors, etc., DSM-IV-TR is chuck full of diagnoses, with detailed descriptions and code numbers for each diagnosis. This book is 952 pages long. It weighs 4.8 pounds.

There is an odd situation in DSM-IV-TR. Really odd. In its entirety, all 952 pages, there is no “No Disorder” option. Therefore, everyone is seen by DSM-IV-TR as sick, the only question being from which sickness(es) they suffer. The annual physical checkup many of us get, usually, unless there is something wrong, ends with “everything is fine.” This, apparently, doesn’t exist in mental health.

I have always felt that I was a crummy writer, starting from college and thereafter (including medical school, internship, National Institute of Mental Health, Psychiatric Residency). However, in writing this poorly written piece, while trudging through DSM-IV-TR, I found 315.2 – “Disorder of Written Expression.” It was an AH-HA moment. I may be a crummy writer, but it’s because I have a disease. Criteria, according to DSM-IV-TR, for this disease (315.2) are 3:

  • a) Writing skills below those expected given the person’s chronological age, measured intelligence and age appropriate education;
  • b) The disturbance in criterion A significantly interferes with academic achievement or activities of daily living that require the composition of written texts (e.g, writing grammatically correct sentences and organized paragraphs);
  • c) If a sensory deficit is present, the difficulties in writing skills are in excesses of those usually associated with it.

Read entire article:  http://www.huffingtonpost.com/ronald-ricker/life-is-not-a-mental-diso_b_644606.html

« Return to news items


Share

Pfizer Makes Bank from DrugsThat Can Kill You—To say Pfizers been accused of wrongdoing is like saying BP had an oil spill

Monday, July 12th, 2010

AlterNet
By Martha Rosenberg
July 10, 2010

The drug company Pfizer is best known for Lipitor, a drug that brings cholesterol down and Viagra, a drug that brings other things up.

But the “world’s largest research-based pharmaceutical company” which sits between Goldman Sachs and Marathon Oil on the Fortune 500, is also closely associated with a seemingly never-ending series of scandals.

To say Pfizer’s been accused of wrongdoing is like saying BP had an oil spill. Other drug companies have a portfolio of products, Pfizer has a portfolio of scandals including, but not limited to, Chantix, Lipitor, Viagra, Geodon, Trovan, Bextra, Celebrex, Lyrica, Zoloft, Halcion and drugs for osteoarthritis, Parkinson’s disease, kidney transplants and leukemia.

During one week in June Pfizer 1) agreed to pull its 10-year-old leukemia drug Mylotarg from the market because it caused more, not less patient deaths 2) Suspended pediatric trials of Geodon two months after the FDA said children were being overdosed 3) Suspended trials of tanezumab, an osteoarthritis pain drug, because patients got worse not better, some needing joint replacements (pattern, anyone?) 4) Was investigated by the House for off-label marketing of kidney transplant drug Rapamune and targeting African-Americans 5) Saw a researcher who helped established its Bextra, Celebrex and Lyrica as effective pain meds, Scott S Reuben, MD, trotted off to prison for research fraud 6) was sued by Blue Cross Blue Shield to recoup money it overpaid for Bextra and other drugs 7) received a letter from Sen. Charles Grassley (R-Iowa) requesting its whistleblower policy and 8 ) had its appeal to end lawsuits by Nigerian families who accuse it of illegal trials of the antibiotic Trovan in which 11 children died, rejected by the Supreme Court. And how was your week?

Nor does Pfizer back down when faced with legal troubles.

Even as it was under the probation of a 5-year Corporate Integrity Agreement (CIA) with Health and Human Services for withholding $20 million in Lipitor rebates owed to Medicaid in 2002, it off-label marketed its seizure drug Neurontin and entered into another CIA in 2004.

Read entire article:  http://www.alternet.org/story/147467/

« Return to news items


Share